The Pentapeptide Repeat Proteins MfpA Mt and QnrB4 Exhibit Opposite Effects on DNA Gyrase Catalytic Reactions and on the Ternary Gyrase-DNA-Quinolone Complex
- 1 March 2009
- journal article
- research article
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 191 (5) , 1587-1594
Abstract
MfpA Mt and QnrB4 are two newly characterized pentapeptide repeat proteins (PRPs) that interact with DNA gyrase. The mfpA Mt gene is chromosome borne in Mycobacterium tuberculosis , while qnrB4 is plasmid borne in enterobacteria. We expressed and purified the two PRPs and compared their effects on DNA gyrase, taking into account host specificity, i.e., the effect of MfpA Mt on M. tuberculosis gyrase and the effect of QnrB4 on Escherichia coli gyrase. Whereas QnrB4 inhibited E. coli gyrase activity only at concentrations higher than 30 μM, MfpA Mt inhibited all catalytic reactions of the M. tuberculosis gyrase described for this enzyme (supercoiling, cleavage, relaxation, and decatenation) with a 50% inhibitory concentration of 2 μM. We showed that the D87 residue in GyrA has a major role in the MfpA Mt -gyrase interaction, as D87H and D87G substitutions abolished MfpA Mt inhibition of M. tuberculosis gyrase catalytic reactions, while A83S modification did not. Since MfpA Mt and QnrB4 have been involved in resistance to fluoroquinolones, we measured the inhibition of the quinolone effect in the presence of each PRP. QnrB4 reversed quinolone inhibition of E. coli gyrase at 0.1 μM as described for other Qnr proteins, but MfpA Mt did not modify M. tuberculosis gyrase inhibition by fluoroquinolones. Crossover experiments showed that MfpA Mt also inhibited E. coli gyrase function, while QnrB4 did not reverse quinolone inhibition of M. tuberculosis gyrase. In conclusion, our in vitro experiments showed that MfpA Mt and QnrB4 exhibit opposite effects on DNA gyrase and that these effects are protein and species specific.Keywords
This publication has 47 references indexed in Scilit:
- Role of a qnr -Like Gene in the Intrinsic Resistance of Enterococcus faecalis to FluoroquinolonesAntimicrobial Agents and Chemotherapy, 2007
- Vibrio splendidus as the Source of Plasmid-Mediated QnrS-Like Quinolone Resistance DeterminantsAntimicrobial Agents and Chemotherapy, 2007
- Characterization of two potentially universal turn motifs that shape the repeated five‐residues fold—Crystal structure of a lumenal pentapeptide repeat protein from Cyanothece 51142Protein Science, 2006
- Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002–2005Clinical Microbiology and Infection, 2006
- First functional characterization of a singly expressed bacterial type II topoisomerase: The enzyme from Mycobacterium tuberculosisBiochemical and Biophysical Research Communications, 2006
- Mycobacterium tuberculosis DNA Gyrase: Interaction with Quinolones and Correlation with Antimycobacterial Drug ActivityAntimicrobial Agents and Chemotherapy, 2004
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Interaction between DNA Gyrase and Quinolones: Effects of Alanine Mutations at GyrA Subunit Residues Ser 83 and Asp 87Antimicrobial Agents and Chemotherapy, 2001
- Structure and distribution of pentapeptide repeats in bacteriaProtein Science, 1998
- Use of in vitro topoisomerase II assays for studying quinolone antibacterial agentsAntimicrobial Agents and Chemotherapy, 1989